SYNCOM FORMULATIONS (INDIA)
Back to Balance Sheet
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Total Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2017 | |
|---|---|---|---|---|---|
| Total Assets | ₹416 Cr | ₹407 Cr | ₹378 Cr | ₹308 Cr | ₹184 Cr |
What is the latest Total Assets ratio of SYNCOM FORMULATIONS (INDIA) ?
| Year | Total Assets |
|---|---|
| Mar2025 | ₹416 Cr |
| Mar2024 | ₹407 Cr |
| Mar2023 | ₹378 Cr |
| Mar2022 | ₹308 Cr |
| Mar2017 | ₹184 Cr |
How is Total Assets of SYNCOM FORMULATIONS (INDIA) Trending?
| Years | Total Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹416 Cr | 2.18 | |
| Mar2024 | ₹407 Cr | 7.69 | |
| Mar2023 | ₹378 Cr | 22.58 | |
| Mar2022 | ₹308 Cr | 67.59 | |
| Mar2017 | ₹184 Cr | - | |
Compare Total Assets of peers of SYNCOM FORMULATIONS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNCOM FORMULATIONS (INDIA) | ₹1,270.9 Cr | 13.8% | -5.3% | -24.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹386,341.0 Cr | -1.8% | -6.4% | -10.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,401.0 Cr | -0.3% | -5.5% | 8.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,175.0 Cr | -0.1% | 4% | 18.7% | Stock Analytics | |
| CIPLA | ₹107,100.0 Cr | 1% | -12.3% | -5.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,715.9 Cr | -4.6% | -7% | 1.8% | Stock Analytics | |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNCOM FORMULATIONS (INDIA) | 13.8% |
-5.3% |
-24.6% |
| SENSEX | -1% |
-4.7% |
6% |
You may also like the below Video Courses